Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Recently published
    • Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Recently published
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
Linking epigenetic dysregulation, mitochondrial impairment, and metabolic dysfunction in SBMA motor neurons
Naemeh Pourshafie, … , Christopher Grunseich, Kenneth H. Fischbeck
Naemeh Pourshafie, … , Christopher Grunseich, Kenneth H. Fischbeck
Published July 9, 2020
Citation Information: JCI Insight. 2020;5(13):e136539. https://doi.org/10.1172/jci.insight.136539.
View: Text | PDF
Research Article Genetics Neuroscience

Linking epigenetic dysregulation, mitochondrial impairment, and metabolic dysfunction in SBMA motor neurons

  • Text
  • PDF
Abstract

Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disorder caused by a polyglutamine expansion in the androgen receptor (AR). Using gene expression analysis and ChIP sequencing, we mapped transcriptional changes in genetically engineered patient stem cell–derived motor neurons. We found that transcriptional dysregulation in SBMA can occur through AR-mediated histone modification. We detected reduced histone acetylation, along with decreased expression of genes encoding compensatory metabolic proteins and reduced substrate availability for mitochondrial function. Furthermore, we found that pyruvate supplementation corrected this deficiency and improved mitochondrial function and SBMA motor neuron viability. We propose that epigenetic dysregulation of metabolic genes contributes to reduced mitochondrial ATP production. Our results show a molecular link between altered epigenetic regulation and mitochondrial metabolism that contributes to neurodegeneration.

Authors

Naemeh Pourshafie, Ester Masati, Eric Bunker, Alec R. Nickolls, Parisorn Thepmankorn, Kory Johnson, Xia Feng, Tyler Ekins, Christopher Grunseich, Kenneth H. Fischbeck

×

Figure 4

Reduced phosphorylation of proteins in the AMPK signaling pathway in SBMA iMNs.

Options: View larger image (or click on image) Download as PowerPoint
Reduced phosphorylation of proteins in the AMPK signaling pathway in SBM...
Heatmaps represents log2 fold changes (average ratio of signal intensity of phosphorylated antibody/average signal intensity of antibody). Signals were detected across 6 replicates of phosphorylation-specific antibodies and their nonphosphorylated pairs. (A) AMPK phosphorylation. (B) mTORC1 signaling and protein synthesis. (C) AMPK-mediated carbohydrate metabolism. (D) AMPK-mediated lipid metabolism. (E) AMPK upstream regulators. N = 3 SBMA, N = 3 control, and N = 3 AR-KO. (F) A simplified schematic of the AMPK signaling summarizing fold changes of SBMA/control relative to AR-KO/control. Proteins with SBMA/control and KO/control fold-change differences more than 1 SD (red) from the mean were identified as having overall increased activation (hyperphosphorylation). Fold-change differences below 1 SD (blue) indicate an overall decreased activity (hypophosphorylation). Fold-change differences within 1 SD of the mean indicates no difference between AR-KO/control and SBMA/control. iMNs were treated with 10 nM DHT.
Follow JCI Insight:
Copyright © 2021 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts